122 related articles for article (PubMed ID: 10077015)
21. Comparison of manganese biodistribution and MR contrast enhancement in rats after intravenous injection of MnDPDP and MnCl2.
Ni Y; Petré C; Bosmans H; Miao Y; Grant D; Baert AL; Marchal G
Acta Radiol; 1997 Jul; 38(4 Pt 2):700-7. PubMed ID: 9245965
[TBL] [Abstract][Full Text] [Related]
22. First pass of an MR susceptibility contrast agent through normal and ischemic heart: gradient-recalled echo-planar imaging.
Wendland MF; Saeed M; Masui T; Derugin N; Higgins CB
J Magn Reson Imaging; 1993; 3(5):755-60. PubMed ID: 8400562
[TBL] [Abstract][Full Text] [Related]
23. Overview of MnDPDP as a pancreas-specific contrast agent for MR imaging.
Ahlström H; Gehl HB
Acta Radiol; 1997 Jul; 38(4 Pt 2):660-4. PubMed ID: 9245961
[TBL] [Abstract][Full Text] [Related]
24. Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement.
Wendland MF; Saeed M; Yu KK; Roberts TP; Lauerma K; Derugin N; Varadarajan J; Watson AD; Higgins CB
Magn Reson Med; 1994 Sep; 32(3):319-29. PubMed ID: 7984064
[TBL] [Abstract][Full Text] [Related]
25. The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit.
Grant D; Blazak WF; Brown GL
Acta Radiol; 1997 Jul; 38(4 Pt 2):759-69. PubMed ID: 9245972
[TBL] [Abstract][Full Text] [Related]
26. Identification of myocardial reperfusion with echo planar magnetic resonance imaging. Discrimination between occlusive and reperfused infarctions.
Saeed M; Wendland MF; Yu KK; Lauerma K; Li HT; Derugin N; Cavagna FM; Higgins CB
Circulation; 1994 Sep; 90(3):1492-501. PubMed ID: 7522135
[TBL] [Abstract][Full Text] [Related]
27. Spectroscopic and metabolic effects of MnCl2 and MnDPDP on the isolated and perfused rat heart.
Vander Elst L; Colet JM; Muller RN
Invest Radiol; 1997 Oct; 32(10):581-8. PubMed ID: 9342116
[TBL] [Abstract][Full Text] [Related]
28. Effects of manganese dipyridoxyl diphosphate, dipyridoxyl diphosphate--, and manganese chloride on cardiac function. An experimental study in the Langendorff perfused rat heart.
Brurok H; Schjøtt J; Berg K; Karlsson JO; Jynge P
Invest Radiol; 1995 Mar; 30(3):159-67. PubMed ID: 7797414
[TBL] [Abstract][Full Text] [Related]
29. General toxicology of MnDPDP.
Larsen LE; Grant D
Acta Radiol; 1997 Jul; 38(4 Pt 2):770-9. PubMed ID: 9245973
[TBL] [Abstract][Full Text] [Related]
30. MnDPDP as a negative hepatic contrast agent: evaluation of STIR imaging compared with T1-weighted SE and GE techniques.
Halavaara JT; Lamminen AE
J Comput Assist Tomogr; 1997; 21(1):94-9. PubMed ID: 9022776
[TBL] [Abstract][Full Text] [Related]
31. Reversible and irreversible injury in the reperfused myocardium: differentiation with contrast material-enhanced MR imaging.
Saeed M; Wendland MF; Takehara Y; Higgins CB
Radiology; 1990 Jun; 175(3):633-7. PubMed ID: 2111568
[TBL] [Abstract][Full Text] [Related]
32. Thallium-like test for myocardial viability with MnDPDP-enhanced MRI.
Wendland MF; Saeed M; Bremerich J; Arheden H; Higgins CB
Acad Radiol; 2002 May; 9 Suppl 1():S82-3. PubMed ID: 12019904
[No Abstract] [Full Text] [Related]
33. Axon tracing in the adult rat optic nerve and tract after intravitreal injection of MnDPDP using a semiautomatic segmentation technique.
Olsen Ø; Thuen M; Berry M; Kovalev V; Petrou M; Goa PE; Sandvig A; Haraldseth O; Brekken C
J Magn Reson Imaging; 2008 Jan; 27(1):34-42. PubMed ID: 18157895
[TBL] [Abstract][Full Text] [Related]
34. Cardiac metal contents after infusions of manganese. An experimental evaluation in the isolated rat heart.
Brurok H; Berg K; Sneen L; Grant D; Karlsson JO; Jynge P
Invest Radiol; 1999 Jul; 34(7):470-6. PubMed ID: 10399637
[TBL] [Abstract][Full Text] [Related]
35. Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images.
Liou J; Lee JK; Borrello JA; Brown JJ
Magn Reson Imaging; 1994; 12(1):71-9. PubMed ID: 8295510
[TBL] [Abstract][Full Text] [Related]
36. MnDPDP-enhanced magnetization transfer MR imaging: implications for effective liver imaging.
Halavaara J; Abo-Ramadan U; Markkola A; Aronen H; Häkkinen AM
Magn Reson Imaging; 2003 Jan; 21(1):47-50. PubMed ID: 12620545
[TBL] [Abstract][Full Text] [Related]
37. Mangafodipir as a cardioprotective adjunct to reperfusion therapy: a feasibility study in patients with ST-segment elevation myocardial infarction.
Karlsson JE; El-Saadi W; Ali M; Puskar W; Skogvard P; Engvall JE; Andersson RG; Maret E; Jynge P
Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):39-45. PubMed ID: 27533964
[TBL] [Abstract][Full Text] [Related]
38. Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma.
Burkill GJ; Mannion EM; Healy JC
Clin Radiol; 2001 Jan; 56(1):67-71. PubMed ID: 11162701
[TBL] [Abstract][Full Text] [Related]
39. Clinical implications of studies with MnDPDP in animal models of hepatic abnormalities.
Ni Y; Marchal G
Acta Radiol; 1997 Jul; 38(4 Pt 2):724-31. PubMed ID: 9245968
[TBL] [Abstract][Full Text] [Related]
40. MR imaging assessment of the kinetics of P846, a new gadolinium-based MR contrast medium, in ischemically injured myocardium.
Jacquier A; Wendland M; Do L; Robert P; Corot C; Higgins CB; Saeed M
Contrast Media Mol Imaging; 2008; 3(3):112-9. PubMed ID: 18548477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
